Company intelligence / Profile preview

Helicos BioSciences Corporation

Cambridge, Massachusetts, United Statesen.wikipedia.org ↗

Ownership: Private
Development stage: Commercial

Overview

The company developed and commercialized the first DNA-sequencing instrument to operate by imaging individual DNA molecules. Their technology enabled genetic analysis without DNA ligation or amplification, allowing for simpler sample preparation and elimination of biases introduced by DNA amplification[4].

Modalities: Genetic analysisDNA sequencing
Industry: Molecular Diagnostics

Partnerships

Correlagen Diagnostics, Inc.

Beyond the preview

Go deeper on Helicos BioSciences Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicos BioSciences Corporation.

Explore the full profile